Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
filingDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f404ddc7fa52acf837d5ee16eab7b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93cf5db09f695062abe4dca56c5206c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b289160cb0d56d0b7c40f6cf95cc10a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_189ff1c3cc17cf1e66e3d7b20509d446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_991a598415fff69693cada201412e3a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f999c4fddfbb3aab875ee10a16ccf28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a900942d62d214ac4873f95b4f671af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d5f9e74dcbe89e70e635ed0aecf7b5f |
publicationDate |
2017-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3111931-A4 |
titleOfInvention |
Pharmaceutical composition for cancer treatment containing gossypol and phenformin as active ingredients |
priorityDate |
2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |